| Dr Kevin Fletcher, MD | |
|
41 E Post Rd, White Plains, NY 10601-4615 | |
| (914) 681-1026 | |
| (914) 681-2901 |
| Full Name | Dr Kevin Fletcher |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 41 E Post Rd, White Plains, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477696334 | NPI | - | NPPES |
| 172881 | Other | NY | NYS LISCENSE # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 172881 (New York) | Primary |
| Entity Name | White Plains Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1992255392 PECOS PAC ID: 4981593092 Enrollment ID: O20161219001743 |
News Archive
Kaiser Health News staff writer Julie Appleby examines the potential reach of the Cadillac tax.
Every year, thousands of people are hospitalised because of medicine-related problems. Interactions between medicines, accidentally doubling up on a dose, and adverse effects are some of the factors that can result in hospitalisation. Many of these incidents are potentially avoidable.
Specialty pharmaceutical company LEO Pharma today announced that findings from a Phase III study evaluating PEP005 (ingenol mebutate) Gel 0.05% to treat actinic keratosis (AK), a common pre-cursor to skin cancer, were presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) (Scientific Session Poster Discussion: P105). Results from REGION-I demonstrated treatment with PEP005 Gel once daily for 2 consecutive days.
The finding suggests that tear analysis could not only be an effective means of diagnosing the infection, but also an unrecognised source of its spread, if appropriate preventive measures are not taken, say the authors.
› Verified 3 days ago
| Entity Name | East Post Road Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841767274 PECOS PAC ID: 6406198506 Enrollment ID: O20190419000178 |
News Archive
Kaiser Health News staff writer Julie Appleby examines the potential reach of the Cadillac tax.
Every year, thousands of people are hospitalised because of medicine-related problems. Interactions between medicines, accidentally doubling up on a dose, and adverse effects are some of the factors that can result in hospitalisation. Many of these incidents are potentially avoidable.
Specialty pharmaceutical company LEO Pharma today announced that findings from a Phase III study evaluating PEP005 (ingenol mebutate) Gel 0.05% to treat actinic keratosis (AK), a common pre-cursor to skin cancer, were presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) (Scientific Session Poster Discussion: P105). Results from REGION-I demonstrated treatment with PEP005 Gel once daily for 2 consecutive days.
The finding suggests that tear analysis could not only be an effective means of diagnosing the infection, but also an unrecognised source of its spread, if appropriate preventive measures are not taken, say the authors.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Fletcher, MD 41 E Post Rd, White Plains, NY 10601-4615 Ph: (914) 681-1026 | Dr Kevin Fletcher, MD 41 E Post Rd, White Plains, NY 10601-4615 Ph: (914) 681-1026 |
News Archive
Kaiser Health News staff writer Julie Appleby examines the potential reach of the Cadillac tax.
Every year, thousands of people are hospitalised because of medicine-related problems. Interactions between medicines, accidentally doubling up on a dose, and adverse effects are some of the factors that can result in hospitalisation. Many of these incidents are potentially avoidable.
Specialty pharmaceutical company LEO Pharma today announced that findings from a Phase III study evaluating PEP005 (ingenol mebutate) Gel 0.05% to treat actinic keratosis (AK), a common pre-cursor to skin cancer, were presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) (Scientific Session Poster Discussion: P105). Results from REGION-I demonstrated treatment with PEP005 Gel once daily for 2 consecutive days.
The finding suggests that tear analysis could not only be an effective means of diagnosing the infection, but also an unrecognised source of its spread, if appropriate preventive measures are not taken, say the authors.
› Verified 3 days ago
Dr. Rachel Aviva Aronow, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-0731 Fax: 314-681-5289 | |
Mrs. Rosaria Dimarco, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-0731 Fax: 914-681-5289 | |
Jay Michael Weissbrot, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 410 N Broadway, White Plains, NY 10603 Phone: 914-984-0353 Fax: 914-948-5237 | |
Dr. Alicia J Rieger, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-0731 Fax: 914-681-5289 | |
Dr. Randi Lynn Sjogren, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 410 N Broadway, White Plains, NY 10603 Phone: 914-948-0353 | |
Judah Roher, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 410 N Broadway, White Plains, NY 10603 Phone: 914-948-0353 Fax: 914-948-5237 | |
Dr. Jesus Jaile-marti, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 41 E Post Rd, White Plains, NY 10601 Phone: 914-681-1026 Fax: 914-681-2901 |